Glutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization

Keyphrases

• Depressive Disorder 100%
• Glutamatergic System 100%
• Technique Optimization 100%
• Neuromodulatory 100%
• Neuromodulation Techniques 66%
• Clinical Evidence 33%
• Patient Outcomes 33%
• Major Depressive Disorder 33%
• Antidepressants 33%
• Treatment Options 33%
• Etiopathogenesis 33%
• Depression Treatment 33%
• Neuroplasticity 33%
• Pathophysiology 33%
• Inappropriate Treatment 33%
• Intervention Strategies 33%
• Non-pharmacological Treatment 33%
• Transcranial Magnetic Stimulation 33%
• Positive Impact 33%
• Transcranial Alternating Current Stimulation (tACS) 33%
• Direct Electrical Stimulation 33%
• Glutamatergic 33%
• Glutamatergic Neurotransmission 33%
• Photobiomodulation 33%
• Neuroimaging Evidence 33%
• Pharmacotherapy 33%
• Glutamatergic Dysfunction 33%
• Glutamate 33%
• Monoamine Hypothesis 33%
• Psychiatric Conditions 33%
• Related Pathway 33%
• Transcutaneous 33%

Medicine and Dentistry

• Depression 100%
• Drug Therapy 66%
• Neuromodulation 66%
• Major Depressive Episode 33%
• Antidepressant 33%
• Etiology 33%
• Treatment of Depression 33%
• Pathophysiology 33%
• Mental Disorder 33%
• Transcranial Magnetic Stimulation 33%
• Neurotransmission 33%
• Glutamic Acid 33%
• Transcranial Alternating Current Stimulation 33%
• Monoamine 33%

Neuroscience

• Depression 100%
• Neuromodulation 66%
• Antidepressant 33%
• Treatment of Depression 33%
• Neuroplasticity 33%
• Mental Disorder 33%
• Major Depressive Disorder 33%
• Transcranial Magnetic Stimulation 33%
• Transcranial Alternating Current Stimulation 33%
• Monoamine 33%
• Glutamic Acid 33%
• Neurotransmission 33%